Antimetastatic Role of Smad4 Signaling in Colorectal Cancer

Gastroenterology

Volumn 138, Issue 3, 2010, Pages

  Zhang, Bixiang ^a   Halder, Sunil K ^a   Kashikar, Nilesh D ^a   Cho, Yong Jig ^a   Datta, Arunima ^a   Gorden, D Lee ^a   Datta, Pran K ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Metastasis; TGF ; TGF Receptor Kinase Inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; GELATINASE B; LY 2109761; NUCLEOSIDE DIPHOSPHATE KINASE NM23; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UROKINASE; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 77249140520     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.004     Document Type: Article

References (22)

1. Massagué J. TGF-β in cancer. Cell 134 (2008) 215-230
2. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003) 577-584
3. Datta P.K., and Mann J.R. Transforming growth factor-β (TGF- β) signaling inhibitors in cancer therapy. In: Jakowlew S.B. (Ed). Transforming growth factor-β in cancer therapy. 1st ed. Volume 2 (2007), Humana Press, Totowa 573-588
4. Bandyopadhyay A., Agyin J.K., Wang L., et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor. Cancer Res 66 (2006) 6714-6721
5. Ge R., Rajeev V., Ray P., et al. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo. Clin Cancer Res 12 (2006) 4315-4330
6. Melisi D., Ishiyama S., Sclabas G.M., et al. LY2109761, a novel transforming growth factor-β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther 7 (2008) 829-840
7. Fransvea E., Angelotti U., Antonaci S., et al. Blocking transforming growth factor-β up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 47 (2008) 1557-1566
8. Miyaki M., Iijima T., Konishi M., et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18 (1999) 3098-3103
9. Losi L., Bouzourene H., and Benhattar J. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. Oncol Rep 17 (2007) 1095-1099
10. Alazzouzi H., Alhopuro P., Salovaara R., et al. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 11 (2005) 2606-2611
11. Kang Y., He W., Tulley S., et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A 102 (2005) 13909-13914
12. Javelaud D., Mohammad K.S., McKenna C.R., et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res 67 (2007) 2317-2324
13. Azuma H., Ehata S., Miyazaki H., et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 97 (2005) 1734-1746
14. Halder S.K., Beauchamp R.D., and Datta P.K. A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7 (2005) 509-521
15. Halder S.K., Rachakonda G., Deane N.G., et al. Smad7 induces hepatic metastasis in colorectal cancer. Br J Cancer 99 (2008) 957-965
16. Sarris M., and Lee C.S. nm23 Protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Eur J Surg Oncol 27 (2001) 170-174
17. Ismail N.I., Kaur G., Hashim H., et al. Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Cancer Cell Int 8 (2008)
18. Zou M., Shi Y., al-Sedairy S., et al. High levels of nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer 68 (1993) 385-388
19. Derynck R., and Zhang Y. TGF-β family signaling: Smad-dependent and Smad-independent pathways. Nature 425 (2003) 577-584
20. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 18 (1999) 15-30
21. Berger J.C., Vander Griend D.J., Robinson V.L., et al. Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol Ther 4 (2005) 805-812
22. Calonge M.J., and Massague J. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. J Biol Chem 274 (1999) 33637-33643